DBV Technologies SA

DBV Technologies SA is a biotechnology company focused on developing innovative food allergy treatment solutions through epicutaneous immunotherapy. The company works to address food allergies by offering novel treatment modalities that could transform patient care.

CCI Score

0.00

March 29

Latest Event

Take Action

So what can you do? Support DBV by shopping, spreading the word, or offering your support.

Shop Alternatives SEE ALL: Amgen

MD Anderson

Thermo Fisher
Use Your Voice OTHER TOOLS
Investigate
Share the Score SUPPORT CCI

PENDING

DBV Technologies SA is currently rated as a Pending.

Not yet scored CCI Score

The CCI rating for this company is not yet available.

Alternatives

Zhengye Biotechnology Holding Limited

Corporation

45.62

Thermo Fisher Scientific

Corporation

11.88

Tyris Therapeutics

Corporation

0.00

INVO Bioscience

Corporation

-20.00

Amgen Inc.

Thousand Oaks, USA

13.63

MD Anderson Cancer Center

Houston, United States

13.52

Gilead Sciences, Inc.

Foster City, USA

1.64

Legend Biotech Corporation

Somerset, United States

1.18

BioNTech SE

Mainz, Germany

-6.57

Iovance Biotherapeutics, Inc.

San Carlos, United States

-24.95

Industries

: 325414; Biological Product (except Diagnostic) Manufacturing
: 541714; Research and Development in Biotechnology (except Nanobiotechnology)
: 621511; Medical Laboratories

Company Directory

Company Directory

Company Directory - DBV Technologies SA

Company Details - DBV Technologies SA

DBV Technologies SA

CCI Score: DBV Technologies SA

Alternatives

Industries